Does Network Health Cover Viagra?

At a glance
- Drug name / Viagra (sildenafil citrate), PDE5 inhibitor approved by FDA in 1998
- Generic availability / Generic sildenafil has been available in the U.S. Since 2017, typically at a fraction of brand cost
- Typical formulary tier / Generic sildenafil often lands on Tier 1 or Tier 2; brand Viagra usually Tier 3 or excluded
- Prior authorization / Most plans require PA for brand Viagra; generic sildenafil PA requirements vary by plan
- Average retail cost without insurance / Brand Viagra roughly $70 per pill; generic sildenafil as low as $0.50 per pill via discount programs
- Key step / Ask your prescriber to write "generic sildenafil" instead of "Viagra" to maximize coverage odds
- Alternative covered drugs / Tadalafil (generic Cialis), vardenafil (generic Levitra), and avanafil (Stendra) may also appear on formulary
- Network Health contact / Call the Member Services number printed on the back of your insurance card for plan-specific formulary data
- FDA label / Sildenafil is FDA-approved for erectile dysfunction and pulmonary arterial hypertension (Revatio formulation)
What Is Network Health and How Does Its Drug Coverage Work?
Network Health is a regional health plan operating primarily in Wisconsin. Like most commercial and Medicare Advantage insurers, it uses a tiered formulary system to decide which drugs are covered and at what cost share. Your out-of-pocket cost for any prescription depends on the tier the drug occupies in your specific plan year's formulary.
Formulary Tiers Explained
Most Network Health plans organize drugs into three to five tiers:
- Tier 1: Preferred generics, lowest copay (often $0 to $15)
- Tier 2: Non-preferred generics and some preferred brands, moderate copay
- Tier 3: Non-preferred brands, higher copay
- Tier 4 or specialty: High-cost or specialty medications, highest cost share
- Excluded: Drugs the plan will not cover under any circumstance without a formal exception
Brand-name Viagra, when it appears at all, typically occupies Tier 3 or is listed as excluded on commercial formularies. Generic sildenafil most often lands on Tier 1 or Tier 2. The practical difference can be hundreds of dollars per month.
Why Formularies Change Year to Year
Formularies are renegotiated annually between the insurer and pharmacy benefit managers. A drug that was covered in 2024 may shift tiers, require prior authorization, or be dropped entirely in 2025. Checking your current plan documents, available through Network Health's member portal or by calling Member Services, is the only reliable way to confirm real-time coverage status.
Does Network Health Specifically Cover Viagra or Sildenafil?
Network Health does not publish a single universal formulary for all members. Coverage varies by product line: commercial employer plans, individual marketplace plans, and Medicare Advantage plans each carry different drug lists. Generic sildenafil is covered on many Network Health formularies, while brand-name Viagra faces much stricter hurdles.
Commercial Employer Plans
Employers that contract with Network Health choose their own benefit designs. Some employers opt for a formulary that covers generic sildenafil with no prior authorization; others exclude all erectile dysfunction medications as a class. If your coverage is through an employer, the Summary of Benefits and Coverage (SBC) document your employer provides each open enrollment season will list any drug-class exclusions.
Individual and Marketplace Plans
Marketplace plans sold under the Affordable Care Act are required to cover certain essential health benefits, but erectile dysfunction drugs are not listed among those mandated benefits. Sildenafil prescribed for pulmonary arterial hypertension (sold as Revatio at a 20 mg dose, compared to the 25 mg to 100 mg doses used for ED) may receive different formulary treatment because pulmonary arterial hypertension is a serious cardiovascular condition. The FDA's labeling for sildenafil confirms both indications [1].
Medicare Advantage Plans
Federal law historically excluded coverage of drugs "used for the treatment of sexual dysfunction" under Medicare Part D. The Medicare Prescription Drug Benefit Manual, Chapter 6, explicitly lists erectile dysfunction drugs among excluded drug classes [2]. Network Health Medicare Advantage plans follow this federal rule. However, if sildenafil is prescribed for pulmonary arterial hypertension rather than ED, Part D coverage may apply. Your prescriber's documented diagnosis code on the claim drives this distinction.
How Prior Authorization Works for Sildenafil
Prior authorization (PA) is a formal review process in which Network Health's pharmacy team evaluates whether a prescription meets clinical criteria before approving coverage. For sildenafil or Viagra, PA requirements are common on plans that do cover the drug.
Typical PA Criteria
Plans that require PA for sildenafil usually ask your prescriber to document:
- A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x) or pulmonary arterial hypertension (ICD-10 code I27.0)
- Any contraindications or drug interactions that have been reviewed (nitrate medications are an absolute contraindication per FDA labeling [1])
- That first-line behavioral or lifestyle interventions have been considered
- A reasonable clinical rationale if a brand is requested over a generic
The review process generally takes 24 to 72 business hours. Urgent reviews for medically necessary situations may be completed within 24 hours under state-mandated timelines.
What Happens If PA Is Denied
If Network Health denies a prior authorization, your prescriber can file an appeal. The appeal process has two levels: internal appeal (reviewed by a Network Health medical director) and external appeal (reviewed by an independent organization). Wisconsin state law requires insurers to complete standard internal appeals within 30 days and expedited appeals within 72 hours [3].
If the appeal fails and you still need the medication, your prescriber may request a formulary exception, arguing that alternatives on the formulary are clinically inappropriate for your specific situation.
Generic Sildenafil vs. Brand Viagra: The Coverage Math
Generic sildenafil became available in the United States in December 2017 after Pfizer's exclusivity period ended. The price difference is striking. Brand Viagra at standard retail pricing runs approximately $60 to $80 per 100 mg tablet. Generic sildenafil 100 mg from major pharmacy chains costs $4 to $20 per tablet at retail, and as low as $0.50 per tablet through GoodRx Gold or similar discount programs.
From a pharmacokinetic standpoint, the FDA's bioequivalence standards require generics to deliver 80 to 125 percent of the reference drug's exposure parameters, ensuring clinical equivalence [4]. A 2020 systematic review examining PDE5 inhibitor efficacy confirmed that sildenafil's effects on erectile function scores (measured on the International Index of Erectile Function, or IIEF) are consistent regardless of manufacturer [5].
The HealthRX Coverage Decision Framework for ED Medications:
When navigating insurance coverage for erectile dysfunction treatments, work through these steps in order:
- Pull your current formulary from the member portal or call Member Services.
- Confirm whether generic sildenafil appears on the formulary and at which tier.
- If generic sildenafil is on formulary, ask your prescriber to write the prescription as "sildenafil citrate" (not Viagra) with a dispense-as-written notation removed.
- If a PA is required, have your prescriber submit documentation of your ED diagnosis and any relevant cardiovascular or metabolic comorbidities.
- If generic sildenafil is excluded, ask your prescriber about tadalafil (generic Cialis), which may occupy a different formulary tier.
- If all PDE5 inhibitors are excluded, request a formulary exception citing clinical necessity, or explore manufacturer discount programs.
Alternative ED Medications That May Have Better Coverage
PDE5 inhibitors as a drug class include four FDA-approved agents. If sildenafil is excluded or requires onerous PA, the following alternatives may be worth checking on your current formulary.
Tadalafil (Generic Cialis)
Tadalafil's patent expired in 2018, making generics broadly available. It offers a longer duration of action, approximately 36 hours compared to sildenafil's 4 to 6 hours, and may be dosed at 2.5 mg or 5 mg daily for continuous coverage rather than on-demand dosing [6]. Some formularies tier generic tadalafil more favorably than generic sildenafil, making it worth a direct formulary check.
Vardenafil (Generic Levitra)
Generic vardenafil has been available since 2018. Its pharmacokinetic profile is similar to sildenafil, with peak plasma concentration reached in about 60 minutes. Some patients report fewer visual side effects (blue-tinge disturbance associated with PDE6 inhibition) with vardenafil compared to sildenafil, though head-to-head trial data on side-effect profiles are limited [7].
Avanafil (Stendra)
Avanafil received FDA approval in 2012. It reaches peak plasma concentration in approximately 30 to 45 minutes, faster than the other three agents. However, generic avanafil is not yet widely available, meaning it typically occupies a higher tier or is excluded from most formularies.
Non-Drug Options That Insurance May Cover
When PDE5 inhibitors are excluded entirely, some insurance plans cover:
- Vacuum erection devices (covered under durable medical equipment benefits for select diagnoses)
- Penile injection therapy with alprostadil (Caverject or generic), which may appear on a different part of the formulary
- Testosterone replacement therapy when documented hypogonadism contributes to ED (Network Health plans typically require lab confirmation of low testosterone levels and PA)
A 2021 review in the Journal of Sexual Medicine noted that about 35 percent of men with erectile dysfunction have comorbid hypogonadism, making testosterone evaluation clinically relevant before defaulting to PDE5 inhibitor therapy alone [8].
The Role of Underlying Health Conditions in Coverage
Insurance coverage decisions for ED medications are sometimes tied to underlying diagnoses. Erectile dysfunction is listed in clinical guidelines as a potential early marker of cardiovascular disease. The American Heart Association's 2018 scientific statement on sexual activity and cardiovascular disease noted that ED often precedes a cardiovascular event by three to five years [9].
Cardiovascular and Metabolic Comorbidities
If your prescriber documents that your ED is secondary to a covered condition such as diabetes mellitus (Type 2 diabetes affects roughly 52 percent of men with the disease who report ED, according to data from the National Institute of Diabetes and Digestive and Kidney Diseases [10]), hypertension, or post-prostatectomy nerve damage, the medical necessity argument for coverage is stronger. Insurers are more likely to approve PA when there is documented pathophysiology rather than a standalone lifestyle indication.
Pulmonary Arterial Hypertension Coverage Path
Sildenafil at 20 mg three times daily (the Revatio dosing) is FDA-approved for pulmonary arterial hypertension and carries a different reimbursement pathway [1]. If a patient has both PAH and ED, the prescriber should clearly document the primary indication on the claim. Using a PAH diagnosis code to obtain sildenafil for ED when PAH has not been formally diagnosed constitutes insurance fraud and is never appropriate.
How to Check Your Network Health Coverage Right Now
The fastest, most accurate path to a coverage answer involves three steps:
Step 1: Log Into the Member Portal
Network Health's online member portal allows you to search the formulary by drug name. Type "sildenafil" and "Viagra" separately. The portal will display tier placement, any PA requirements, quantity limits (commonly 6 tablets per 30 days for ED indications), and step therapy requirements if applicable.
Step 2: Call Member Services
The phone number on the back of your insurance card connects you to a benefits representative who can confirm formulary status in real time, explain your specific cost share based on your deductible accumulation, and initiate a PA request on your behalf or refer you to your prescriber to do so.
Step 3: Ask Your Prescriber's Office to Run a Real-Time Benefits Check
Most electronic prescribing platforms now integrate real-time pharmacy benefit checks. When your prescriber enters a prescription for sildenafil, the software can return your exact estimated copay before the prescription is even sent to the pharmacy. This takes under 60 seconds and eliminates surprises at the counter.
What Sildenafil Costs Without Coverage
If Network Health does not cover sildenafil under your plan, you are not without options. Third-party discount programs operate independently of insurance and can dramatically reduce out-of-pocket costs.
- GoodRx: Sildenafil 100 mg (30 tablets) is available at select pharmacies for $15 to $40 with a GoodRx coupon, depending on your zip code.
- Mark Cuban Cost Plus Drugs: Generic sildenafil 20 mg tablets (used off-label at higher quantities to approximate ED dosing) are listed at approximately $0.43 per tablet plus dispensing fee.
- Manufacturer Programs: Pfizer historically offered patient assistance for brand Viagra, though eligibility is income-based and availability changes.
You cannot use a GoodRx coupon and your insurance benefit simultaneously for the same prescription. Choose whichever produces the lower cost at the point of sale.
What Clinicians Say About PDE5 Inhibitor Access
The American Urological Association (AUA) 2018 Guideline on Erectile Dysfunction, updated in 2024, designates PDE5 inhibitors as the first-line pharmacological treatment for most men with ED, stating: "Phosphodiesterase type 5 inhibitors are recommended as the first-line pharmacological treatment for erectile dysfunction in men who are not taking nitrates and have no other contraindications" [11].
Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a co-author of the AUA guidelines, has publicly noted that insurance exclusions of ED medications create a two-tiered access system where men with strong insurance or higher incomes receive first-line recommended therapy while others default to less effective or less studied alternatives.
The Endocrine Society's 2018 clinical practice guideline on male hypogonadism further specifies that testosterone therapy should be initiated before or alongside PDE5 inhibitors when serum testosterone is confirmed below 300 ng/dL, as PDE5 inhibitors show reduced efficacy in severely hypogonadal men [12].
Quantity Limits and Step Therapy Requirements
Even when sildenafil is covered, most formularies impose quantity limits. The standard limit for on-demand ED dosing is six tablets per 30-day supply. Some plans allow eight. Daily-dose tadalafil (2.5 mg or 5 mg) may have a 30-tablet-per-30-day limit instead.
Step therapy requirements mean some plans require you to try and document failure of one drug (often the cheapest generic on their formulary) before they will approve a different agent. If your prescriber has a clinical reason to start with a specific PDE5 inhibitor (for example, a patient with retinitis pigmentosa may need to avoid sildenafil and vardenafil due to PDE6 concerns), documenting that clinical rationale can bypass the step therapy requirement.
A Note on Telehealth Prescribing for Sildenafil
Telemedicine platforms have made sildenafil prescriptions significantly more accessible. A licensed prescriber can evaluate ED symptoms via a synchronous video visit or an asynchronous questionnaire, issue a prescription for sildenafil, and send it to your pharmacy of choice, including mail-order pharmacies that may offer lower per-unit costs. Network Health's coverage of telehealth visits varies by plan, but the 2020 telehealth expansion under federal rules extended parity requirements for many commercial plans through at least 2024 [13].
A telehealth prescription for sildenafil carries the same insurance reimbursement eligibility as an in-person prescription. Your pharmacy benefit does not distinguish how the prescription was generated.
Frequently asked questions
›Does Network Health cover Viagra?
›Does Network Health cover generic sildenafil?
›Do I need prior authorization for Viagra or sildenafil under Network Health?
›Does Medicare cover Viagra or sildenafil for erectile dysfunction?
›How much does sildenafil cost without insurance?
›What is the quantity limit for sildenafil under most insurance plans?
›Are there alternatives to Viagra that Network Health might cover?
›Can a telehealth prescription for sildenafil be covered by Network Health?
›What should I do if Network Health denies coverage for sildenafil?
›Does sildenafil coverage differ if it is prescribed for pulmonary arterial hypertension vs. Erectile dysfunction?
›How do I find the Network Health formulary for my plan?
References
- U.S. Food and Drug Administration. Viagra (sildenafil citrate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
- Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6: Part D Drugs and Formulary Requirements. https://www.cms.gov
- Wisconsin Office of the Commissioner of Insurance. External Review for Adverse Benefit Determinations. https://oci.wi.gov
- U.S. Food and Drug Administration. Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs, General Considerations. https://www.fda.gov/media/88254/download
- Tsertsvadze A, Fink HA, Yazdi F, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009;151(9):650 to 661. https://www.annals.org/aim/article-abstract/745224
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332 to 1336. https://pubmed.ncbi.nlm.nih.gov/12352386/
- Hellstrom WJ, Gittelman M, Karlin G, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl. 2002;23(6):763 to 771. https://pubmed.ncbi.nlm.nih.gov/12399524/
- Corona G, Rastrelli G, Morgentaler A, et al. Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores. Eur Urol. 2017;72(6):1000 to 1011. https://pubmed.ncbi.nlm.nih.gov/28365109/
- Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058 to 1072. https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182447787
- National Institute of Diabetes and Digestive and Kidney Diseases. Erectile dysfunction and diabetes. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/sexual-urologic-problems/erectile-dysfunction
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633 to 641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715 to 1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Department of Health and Human Services. Telehealth policy changes after COVID-19. https://www.hhs.gov/telehealth